RecruitingAccepts healthy volunteers
Oxygenation in Vascular Lesions of the Colon
University of Chicago · NCT06230731
View Study & Apply (opens in a new tab)
Opens the official ClinicalTrials.gov record, with the study team’s contacts. Bored Studies doesn’t enroll anyone.
Key facts
- Compensation
- Not posted. Ask the study team before screening.
- Who can join
- Ages 18–89 · All sexes
- Healthy volunteers
- Accepted
- Study type
- Interventional · Not applicable
- Target enrollment
- 30
- US sites recruiting
- 1
- Study start
- February 1, 2024
- Record last updated
- July 9, 2026
Status re-checked against ClinicalTrials.gov within the last 12 hours.
What the study is about
The goal of this clinical trial is to evaluate oxygenation in the colon in people with acquired vascular abnormalities in the proximal colon.
Being studied: Oxygen saturation
Conditions: Vascular Lesion
Eligibility criteria
Copied from the official record. The study team makes the final decision at screening.
Show full criteria
Inclusion Criteria
- Undergo standard of care colonoscopy
- People with a history of vascular lesions of the colon
- People with healthy colon
- 18 - 89 years of age
Exclusion Criteria
- Age \< 18 years
- Age > 90 years
- People with ulcerations in at ascending colon opposite the ileocecal valve
- Previous colon surgery
Recruiting US locations
University of Chicago
Chicago, IL 60637
Site contact: Joel Pekow, MD · (773) 834-8632 · jpekow@bsd.uchicago.edu
Study contacts (from the official record)
- Joel Pekow, MD · (773) 834-8632 · jpekow@bsd.uchicago.edu
- Kristi Kearney, RN · 773-834-7414 · Kkearney@bsd.uchicago.edu
Similar studies in Illinois
All healthy volunteers studies in Illinois →- RecruitingHealthy volunteers
J-RISE: Relevant Implementation Strategies to Eliminate the Social and Structural Barriers to HIV Services Among Justice-involved Black Men Who Have Sex With Men and Other Key Populations
University of Chicago
- Location
- Chicago, IL
- Eligibility basics
- Ages 18+
- RecruitingHealthy volunteersPhase 1/Phase 2
Phase 1/2 Study of Respiratory Syncytial Virus and Human Metapneumovirus (RSV+HMPV) Vaccine Candidate in Adults 60 Years of Age and Older
Sanofi
- Location
- Melrose Park, IL + 49 other US sites
- Eligibility basics
- Ages 60+
- RecruitingHealthy volunteersPhase 1
A Study to Assess Safety, Tolerability, and How Single and Multiple Injections or Infusions of ABBV-313 Affects the Body of Adult Participants
AbbVie
- Location
- Grayslake, IL + 1 other US site
- Eligibility basics
- Ages 18–55
- RecruitingHealthy volunteersPhase 1
A Study to Evaluate the Safety and Pharmacokinetics of Multiple Doses Upadacitinib, Tofacitinib, and Baricitinib in Healthy Adult Volunteers
AbbVie
- Location
- Grayslake, IL
- Eligibility basics
- Ages 18–65